20h
GlobalData on MSNRegeneron’s macular oedema therapy shows promise in Phase III trialIn the trial, subjects treated with the Eylea HD 8mg injection every eight weeks showed non-inferior visual acuity gains.
Loss to follow-up higher among men who are Black or Hispanic, or those who must travel farther to care facilities.
The following is a summary of “Evaluating lipid-lowering drug targets for full-course diabetic retinopathy,” published in the ...
Google and Perceptra, a Google technology licensing partner, are joining forces to provide AI-powered diabetic-retinopathy (DR) screening to around 1 million people in underserved communities across ...
If you have diabetes, following a nutritious diet that promotes healthy blood sugar levels is critical. But it can feel challenging to constantly shop for, plan, and prepare diabetes-friendly ...
Diabetic retinopathy—damage to the eyes that can lead to loss of vision—could be helped by cannabis use. An animal study found that cannabis use could be protective against the development of diabetic ...
Treatment of hypertensive retinopathy begins with controlling hypertension. Some of the complications can be treated by an ophthalmologist with injectable medications into the eye as well as laser ...
Diabetic retinopathy is a common complication in people with type 1 and type 2 diabetes, progressing from mild, moderate, and severe non-proliferative diabetic retinopathy to proliferative diabetic ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins Some states have laws and ethical rules regarding solicitation and ...
Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. While pericytes are important regulators of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results